The No1 Ethical retailer for Books, CD’s, DVD’s & Games
30 Day Refund Guarantee

Drug Treatments and Dementia (Bradford Dementia Group Good Practice Guides)

Drug Treatments and Dementia (Bradford Dementia Group Good Practice Guides)

by StephenHopker (Author)

  • Used

    Paperback 1999

    $3.25
Synopsis

This comprehensive book looks at the use of medication in dementia care. It gives guidance on the drug treatments which are currently available to people with dementia, detailing how they can be used, and assessing their effectiveness. It considers the clinical value of the new cognitive enhancing drugs like donezepil. It also looks at the use of older drugs, describing the situation in the United States where controversy over the misuse of treatments such as antipsychotic medications in nursing homes has led to detailed and legally enforced controls over prescribing these drugs.

Drug Treatments and Dementia highlights the need for evidence-based practice taking into account the full range of factors which influence the success or failure of a drug treatments. It advocates the prescription of medication as just one part in a complete care reflecting the specific situation and needs of the person with dementia. This guide will inform the practice of carers and clinicians and be of interest to anyone involved with the care or treatment of people who are affected by dementia.

$3.25

Save:$14.27 (81%)

Quantity

1 in stock

More Information

Format: Paperback
 Pages: 128
 Publisher: Jessica Kingsley Publishers
Published: 01 Jun 1999
ISBN 10: 185302760X
ISBN 13: 9781853027604

Media Reviews
This is an important topic, and one that has become increasingly relevant over the past few years with the availability of anti-dementia drugs and a greater willingness of health authorities to approve funding. This book is very easy to read and it is well presented in a logical order, with clear headings, use of bullet points and some excellent case studies. The book is well referenced and it also contains some useful appendices on antipsychotic side effects, and dosages of antidepressants. A compact introduction to drug treatments for dementia, that would be suitable for a wide range of healthcare professionals including those working in primary care. It would also be very useful to geriatricians and psychiatrists in various stages of training. It will certainly have a place iin our medical library and I am sure will be frequently used. -- Human Psychopharmacology
This is a stimulating book and I recommend it to all professionals involved in the care of patients suffering from dementia. It should be especially useful to general practitioners, junior doctors and carers from different backgrounds, including interested informal carers. -- Psychiatric Bulletin
Stephen Hopker has produced this excellent book which I would suggest is essential reading for any person interested in or involved with the care or treatment of people with dementia. Although the title might suggest a purely pharmacalogical approach to the subject, the text is extremely articulate, well referenced, sensitive and it is an interesting read. Whilst the main theme is drug treatmens, this beautifully written book explores a wide range of issues involved with the care of a person with dementia. The clear and succinct statements made are thought provoking and stimulate the reader to want to find out more about the topics covered. I thoroughly enjoyed reading this book and would strongly recommend it to anyone interested in this topic. I would add that for those with no interest, this book would prove to be an excellent starting point. -- Signpost
Author Bio
Stephen Hopker has worked as a consultant psychiatrist in Bradford since 1990. As a member of the local Drugs and Therapeutics Committee he has been involved in discussions involving drug treatments in dementia. He currently holds an honorary position within the Bradford Memory Assessment Centre. He has been involved in health education for a number of years, both as a medical tutor and in multi-professional settings. He has a continuing interest in promoting evidence-based health care and is involved with developing clinical governance within Bradford Community Trust.